D.E. Shaw & Co
PBH icon

D.E. Shaw & Co’s Prestige Consumer Healthcare PBH Stock Holding History

D.E. Shaw & Co’s Portfolio PBH Stock Details PBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-50,000
Closed -$1.79M – 4524
2013
Q4 		$1.79M Sell
50,000
-20,000
-29% -$664K ﹤0.01% 2631
2013
Q3 		$2.11M Buy
70,000
+50,000
+250% +$1.63M ﹤0.01% 2373
2013
Q2 		$583K Buy
+20,000
New +$564K ﹤0.01% 3125

Other funds holding PBH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

D.E. Shaw & Co's PBH Position: Q2 2026 in Review

D.E. Shaw & Co reduced its Prestige Consumer Healthcare (PBH) stake by 18% in Q2 2026, selling an estimated $3.46M and leaving 313,778 shares worth $14.8M. The position accounts for 0.01% of the portfolio, ranked #1517.

D.E. Shaw & Co first reported a position in PBH in Q3 2013 and has held it in 35 quarters since. The position peaked at $33.6M in Q3 2025. 320 funds tracked by Wall St. Rank hold PBH as of Q2 2026.

  • D.E. Shaw & Co held 313,778 shares of Prestige Consumer Healthcare worth $14.8M as of Q2 2026.
  • D.E. Shaw & Co sold 67,255 Prestige Consumer Healthcare shares in Q2 2026, an estimated $3.46M.
  • Prestige Consumer Healthcare made up 0.01% of D.E. Shaw & Co's portfolio in Q2 2026, its #1517 holding.
  • D.E. Shaw & Co first reported a position in Prestige Consumer Healthcare in Q3 2013 and has held it in 35 quarters since.
  • D.E. Shaw & Co's Prestige Consumer Healthcare position peaked at $33.6M in Q3 2025.
  • 320 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.